Takeda Pharmaceutical TAK
NYSE TAK
$17.86 -0.01 (-0.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Short-term Investments (2018 - 2026)

Updated

Takeda Pharmaceutical's Short-term Investments came in at $2.91 billion for the quarter ended Jun 30, 2026, up 24.7% from $2.33 billion a year earlier and up 3.6% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Short-term Investments (2018 - 2026) Analysis & Trends

As of Mar 31, 2026, Takeda Pharmaceutical's Short-term Investments was $2.92 billion, up 26.8% from the prior year.

  • Short-term Investments carries a five-year compound annual growth rate of 5.6% (years ended Mar 2021 to Mar 2026).
  • Going back by year, Short-term Investments was $2.31 billion in the year ended Mar 31, 2025 (-2.5%), $2.36 billion in the year ended Mar 31, 2024 (+14.1%), $2.07 billion in the year ended Mar 31, 2023 (-0.5%) and $2.08 billion in the year ended Mar 31, 2022 (-6.5%).
  • The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Short-term Investments in data going back to the quarter ended Mar 31, 2018.
  • Year-over-year, Short-term Investments has increased for seven consecutive quarters, with growth averaging 14.8% over the last eight quarters.
  • The fastest year-over-year change in Short-term Investments over five years came in the quarter ended Dec 31, 2024 (growth of 43.4%), and the weakest in the quarter ended Sep 30, 2024 (a decline of 19.1%).
  • Business Quant data shows TAK's Short-term Investments at $2.81 billion (quarter ended Mar 31, 2026), $2.75 billion (quarter ended Dec 31, 2025) and $2.48 billion (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Takeda Pharmaceutical 2.58 Bn -23.92 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.91 Bn
Mar 31, 2026 2.81 Bn
Dec 31, 2025 2.75 Bn
Sep 30, 2025 2.48 Bn
Jun 30, 2025 2.33 Bn
Mar 31, 2025 2.30 Bn
Dec 31, 2024 2.61 Bn
Sep 30, 2024 1.75 Bn
Jun 30, 2024 2.31 Bn
Mar 31, 2024 2.30 Bn
Dec 31, 2023 1.82 Bn
Sep 30, 2023 2.17 Bn
Jun 30, 2023 2.14 Bn
Mar 31, 2023 2.11 Bn
Dec 31, 2022 1.95 Bn
Sep 30, 2022 2.38 Bn
Jun 30, 2022 2.20 Bn
Mar 31, 2022 2.01 Bn
Jun 30, 2021 2.37 Bn
Mar 31, 2021 2.23 Bn
API Access

Takeda Pharmaceutical Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=TAK&period=max&api_key=YOUR_API_KEY